Specific Expression of PLK-1 in Nodular Lymphocyte Predominant Hodgkin Lymphoma Correlates with Disease Stage, and Selective PLK-1 Inhibition with Volasertib May Constitute a Viable Therapeutic Alternative-MedSci.cn

Specific Expression of PLK-1 in Nodular Lymphocyte Predominant Hodgkin Lymphoma Correlates with Disease Stage, and Selective PLK-1 Inhibition with Volasertib May Constitute a Viable Therapeutic Alternative

Weiss, J; Niravel, B; Brown, N; Wilcox, R; Inamdar, K; Murga-Zamalloa, C

LABORATORY INVESTIGATION, 2021; 101 (SUPPL 1): 905

科室
- - 订阅+
  - 更多科室
工具
服务